Lower Dose FOLFIRINOX Effective, Safer for Pancreatic Cancer Lower Dose FOLFIRINOX Effective, Safer for Pancreatic Cancer
With practice patterns varying widely, investigators call for a standardized approach to FOLFIRINOX dose reduction in metastatic pancreatic cancer.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Gastroenterology News Source Type: news
More News: Cancer | Cancer & Oncology | Gastroenterology | Hematology | Pancreas | Pancreatic Cancer